nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzatropine—CYP2C19—coronary artery disease	0.314	1	CbGaD
Benzatropine—CYP2C19—Gemfibrozil—coronary artery disease	0.0489	0.109	CbGbCtD
Benzatropine—CYP2C19—Clopidogrel—coronary artery disease	0.0424	0.0948	CbGbCtD
Benzatropine—CYP2C19—Telmisartan—coronary artery disease	0.0371	0.0829	CbGbCtD
Benzatropine—CYP2C19—Timolol—coronary artery disease	0.0299	0.0668	CbGbCtD
Benzatropine—CYP2C19—Rosuvastatin—coronary artery disease	0.0273	0.0611	CbGbCtD
Benzatropine—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.0266	0.0595	CbGbCtD
Benzatropine—CYP2C19—Simvastatin—coronary artery disease	0.0254	0.0568	CbGbCtD
Benzatropine—CYP2C19—Lovastatin—coronary artery disease	0.0249	0.0556	CbGbCtD
Benzatropine—CYP2D6—Niacin—coronary artery disease	0.0244	0.0546	CbGbCtD
Benzatropine—CYP2D6—Timolol—coronary artery disease	0.0227	0.0508	CbGbCtD
Benzatropine—CYP2C19—Atorvastatin—coronary artery disease	0.0226	0.0506	CbGbCtD
Benzatropine—CYP2C19—Losartan—coronary artery disease	0.0207	0.0463	CbGbCtD
Benzatropine—CYP2D6—Captopril—coronary artery disease	0.02	0.0447	CbGbCtD
Benzatropine—CYP2D6—Simvastatin—coronary artery disease	0.0193	0.0432	CbGbCtD
Benzatropine—CYP2D6—Pravastatin—coronary artery disease	0.0189	0.0423	CbGbCtD
Benzatropine—CYP2D6—Lovastatin—coronary artery disease	0.0189	0.0423	CbGbCtD
Benzatropine—CYP2D6—Atorvastatin—coronary artery disease	0.0172	0.0385	CbGbCtD
Benzatropine—Cyclizine—SULT1E1—coronary artery disease	0.0018	0.678	CrCbGaD
Benzatropine—Tachycardia—Fenofibrate—coronary artery disease	0.000444	0.00317	CcSEcCtD
Benzatropine—Vision blurred—Niacin—coronary artery disease	0.000441	0.00314	CcSEcCtD
Benzatropine—Confusional state—Ezetimibe—coronary artery disease	0.00044	0.00313	CcSEcCtD
Benzatropine—Dysuria—Timolol—coronary artery disease	0.000438	0.00312	CcSEcCtD
Benzatropine—Tension—Enalapril—coronary artery disease	0.000437	0.00311	CcSEcCtD
Benzatropine—Vision blurred—Pravastatin—coronary artery disease	0.000434	0.00309	CcSEcCtD
Benzatropine—Nervousness—Enalapril—coronary artery disease	0.000433	0.00308	CcSEcCtD
Benzatropine—Feeling abnormal—Rosuvastatin—coronary artery disease	0.000432	0.00308	CcSEcCtD
Benzatropine—Tension—Telmisartan—coronary artery disease	0.000431	0.00307	CcSEcCtD
Benzatropine—Hypersensitivity—Ticagrelor—coronary artery disease	0.000429	0.00306	CcSEcCtD
Benzatropine—Nervousness—Telmisartan—coronary artery disease	0.000427	0.00304	CcSEcCtD
Benzatropine—Feeling abnormal—Acetylsalicylic acid—coronary artery disease	0.00042	0.00299	CcSEcCtD
Benzatropine—Vision blurred—Enalapril—coronary artery disease	0.00042	0.00299	CcSEcCtD
Benzatropine—Tension—Captopril—coronary artery disease	0.000419	0.00299	CcSEcCtD
Benzatropine—Confusional state—Simvastatin—coronary artery disease	0.000419	0.00299	CcSEcCtD
Benzatropine—Nausea—Penbutolol—coronary artery disease	0.000415	0.00296	CcSEcCtD
Benzatropine—Nervousness—Captopril—coronary artery disease	0.000415	0.00296	CcSEcCtD
Benzatropine—Tension—Perindopril—coronary artery disease	0.000407	0.0029	CcSEcCtD
Benzatropine—Dysuria—Lisinopril—coronary artery disease	0.000406	0.00289	CcSEcCtD
Benzatropine—Nervousness—Perindopril—coronary artery disease	0.000403	0.00287	CcSEcCtD
Benzatropine—Vision blurred—Captopril—coronary artery disease	0.000403	0.00287	CcSEcCtD
Benzatropine—Dry mouth—Valsartan—coronary artery disease	0.000401	0.00285	CcSEcCtD
Benzatropine—Decreased appetite—Fenofibrate—coronary artery disease	0.000396	0.00282	CcSEcCtD
Benzatropine—Dry mouth—Niacin—coronary artery disease	0.00039	0.00277	CcSEcCtD
Benzatropine—Constipation—Fenofibrate—coronary artery disease	0.000389	0.00277	CcSEcCtD
Benzatropine—Hypersensitivity—Rosuvastatin—coronary artery disease	0.000386	0.00275	CcSEcCtD
Benzatropine—Decreased appetite—Lovastatin—coronary artery disease	0.000386	0.00275	CcSEcCtD
Benzatropine—Constipation—Clopidogrel—coronary artery disease	0.000383	0.00273	CcSEcCtD
Benzatropine—Tension—Losartan—coronary artery disease	0.000382	0.00272	CcSEcCtD
Benzatropine—Tachycardia—Olmesartan—coronary artery disease	0.000381	0.00272	CcSEcCtD
Benzatropine—Constipation—Lovastatin—coronary artery disease	0.00038	0.00271	CcSEcCtD
Benzatropine—Vision blurred—Furosemide—coronary artery disease	0.00038	0.00271	CcSEcCtD
Benzatropine—Vomiting—Gemfibrozil—coronary artery disease	0.000379	0.0027	CcSEcCtD
Benzatropine—Confusional state—Pravastatin—coronary artery disease	0.000379	0.0027	CcSEcCtD
Benzatropine—Decreased appetite—Ezetimibe—coronary artery disease	0.000379	0.0027	CcSEcCtD
Benzatropine—Nervousness—Losartan—coronary artery disease	0.000378	0.00269	CcSEcCtD
Benzatropine—Rash—Gemfibrozil—coronary artery disease	0.000376	0.00268	CcSEcCtD
Benzatropine—Dermatitis—Gemfibrozil—coronary artery disease	0.000376	0.00268	CcSEcCtD
Benzatropine—Hypersensitivity—Acetylsalicylic acid—coronary artery disease	0.000375	0.00267	CcSEcCtD
Benzatropine—Feeling abnormal—Fenofibrate—coronary artery disease	0.000375	0.00267	CcSEcCtD
Benzatropine—Constipation—Ezetimibe—coronary artery disease	0.000373	0.00266	CcSEcCtD
Benzatropine—Tachycardia—Niacin—coronary artery disease	0.000373	0.00265	CcSEcCtD
Benzatropine—Dry mouth—Trandolapril—coronary artery disease	0.000372	0.00265	CcSEcCtD
Benzatropine—Dry mouth—Enalapril—coronary artery disease	0.000371	0.00264	CcSEcCtD
Benzatropine—Vomiting—Ticagrelor—coronary artery disease	0.000371	0.00264	CcSEcCtD
Benzatropine—Feeling abnormal—Clopidogrel—coronary artery disease	0.000369	0.00263	CcSEcCtD
Benzatropine—Fentanyl—OPRD1—coronary artery disease	0.000368	0.138	CrCbGaD
Benzatropine—Rash—Ticagrelor—coronary artery disease	0.000367	0.00262	CcSEcCtD
Benzatropine—Dermatitis—Ticagrelor—coronary artery disease	0.000367	0.00261	CcSEcCtD
Benzatropine—Vision blurred—Losartan—coronary artery disease	0.000367	0.00261	CcSEcCtD
Benzatropine—Confusional state—Enalapril—coronary artery disease	0.000367	0.00261	CcSEcCtD
Benzatropine—Feeling abnormal—Lovastatin—coronary artery disease	0.000366	0.00261	CcSEcCtD
Benzatropine—Dry mouth—Telmisartan—coronary artery disease	0.000366	0.00261	CcSEcCtD
Benzatropine—Constipation—Eplerenone—coronary artery disease	0.000365	0.0026	CcSEcCtD
Benzatropine—Decreased appetite—Simvastatin—coronary artery disease	0.000361	0.00257	CcSEcCtD
Benzatropine—Body temperature increased—Fenofibrate—coronary artery disease	0.00036	0.00256	CcSEcCtD
Benzatropine—Feeling abnormal—Ezetimibe—coronary artery disease	0.000359	0.00256	CcSEcCtD
Benzatropine—Tachycardia—Trandolapril—coronary artery disease	0.000356	0.00254	CcSEcCtD
Benzatropine—Dry mouth—Captopril—coronary artery disease	0.000356	0.00253	CcSEcCtD
Benzatropine—Constipation—Simvastatin—coronary artery disease	0.000356	0.00253	CcSEcCtD
Benzatropine—Tachycardia—Enalapril—coronary artery disease	0.000355	0.00253	CcSEcCtD
Benzatropine—Nausea—Gemfibrozil—coronary artery disease	0.000354	0.00252	CcSEcCtD
Benzatropine—Body temperature increased—Clopidogrel—coronary artery disease	0.000354	0.00252	CcSEcCtD
Benzatropine—Feeling abnormal—Eplerenone—coronary artery disease	0.000352	0.00251	CcSEcCtD
Benzatropine—Confusional state—Captopril—coronary artery disease	0.000352	0.0025	CcSEcCtD
Benzatropine—Body temperature increased—Lovastatin—coronary artery disease	0.000351	0.0025	CcSEcCtD
Benzatropine—Tachycardia—Telmisartan—coronary artery disease	0.00035	0.00249	CcSEcCtD
Benzatropine—Nausea—Ticagrelor—coronary artery disease	0.000346	0.00247	CcSEcCtD
Benzatropine—Dry mouth—Perindopril—coronary artery disease	0.000345	0.00246	CcSEcCtD
Benzatropine—Body temperature increased—Ezetimibe—coronary artery disease	0.000345	0.00246	CcSEcCtD
Benzatropine—Feeling abnormal—Simvastatin—coronary artery disease	0.000343	0.00244	CcSEcCtD
Benzatropine—Confusional state—Perindopril—coronary artery disease	0.000341	0.00243	CcSEcCtD
Benzatropine—Decreased appetite—Valsartan—coronary artery disease	0.000341	0.00243	CcSEcCtD
Benzatropine—Tachycardia—Captopril—coronary artery disease	0.00034	0.00242	CcSEcCtD
Benzatropine—Decreased appetite—Olmesartan—coronary artery disease	0.00034	0.00242	CcSEcCtD
Benzatropine—Body temperature increased—Eplerenone—coronary artery disease	0.000337	0.0024	CcSEcCtD
Benzatropine—Dry mouth—Furosemide—coronary artery disease	0.000336	0.00239	CcSEcCtD
Benzatropine—Constipation—Valsartan—coronary artery disease	0.000336	0.00239	CcSEcCtD
Benzatropine—Hypersensitivity—Fenofibrate—coronary artery disease	0.000335	0.00239	CcSEcCtD
Benzatropine—Constipation—Olmesartan—coronary artery disease	0.000334	0.00238	CcSEcCtD
Benzatropine—Decreased appetite—Niacin—coronary artery disease	0.000332	0.00236	CcSEcCtD
Benzatropine—Confusional state—Furosemide—coronary artery disease	0.000332	0.00236	CcSEcCtD
Benzatropine—Rash—Rosuvastatin—coronary artery disease	0.000331	0.00236	CcSEcCtD
Benzatropine—Tachycardia—Perindopril—coronary artery disease	0.00033	0.00235	CcSEcCtD
Benzatropine—Dermatitis—Rosuvastatin—coronary artery disease	0.00033	0.00235	CcSEcCtD
Benzatropine—Hypersensitivity—Clopidogrel—coronary artery disease	0.00033	0.00235	CcSEcCtD
Benzatropine—Body temperature increased—Simvastatin—coronary artery disease	0.000329	0.00234	CcSEcCtD
Benzatropine—Hypersensitivity—Lovastatin—coronary artery disease	0.000328	0.00233	CcSEcCtD
Benzatropine—Tension—Ramipril—coronary artery disease	0.000327	0.00233	CcSEcCtD
Benzatropine—Decreased appetite—Pravastatin—coronary artery disease	0.000327	0.00233	CcSEcCtD
Benzatropine—Nervousness—Ramipril—coronary artery disease	0.000324	0.00231	CcSEcCtD
Benzatropine—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000324	0.00231	CcSEcCtD
Benzatropine—Dry mouth—Losartan—coronary artery disease	0.000324	0.00231	CcSEcCtD
Benzatropine—Feeling abnormal—Olmesartan—coronary artery disease	0.000322	0.00229	CcSEcCtD
Benzatropine—Constipation—Pravastatin—coronary artery disease	0.000321	0.00229	CcSEcCtD
Benzatropine—Rash—Acetylsalicylic acid—coronary artery disease	0.000321	0.00229	CcSEcCtD
Benzatropine—Hypersensitivity—Ezetimibe—coronary artery disease	0.000321	0.00229	CcSEcCtD
Benzatropine—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000321	0.00229	CcSEcCtD
Benzatropine—Confusional state—Losartan—coronary artery disease	0.00032	0.00228	CcSEcCtD
Benzatropine—Tension—Timolol—coronary artery disease	0.00032	0.00228	CcSEcCtD
Benzatropine—Decreased appetite—Trandolapril—coronary artery disease	0.000317	0.00226	CcSEcCtD
Benzatropine—Nervousness—Timolol—coronary artery disease	0.000317	0.00226	CcSEcCtD
Benzatropine—Decreased appetite—Enalapril—coronary artery disease	0.000316	0.00225	CcSEcCtD
Benzatropine—Constipation—Trandolapril—coronary artery disease	0.000312	0.00222	CcSEcCtD
Benzatropine—Decreased appetite—Telmisartan—coronary artery disease	0.000312	0.00222	CcSEcCtD
Benzatropine—Nausea—Rosuvastatin—coronary artery disease	0.000312	0.00222	CcSEcCtD
Benzatropine—Constipation—Enalapril—coronary artery disease	0.000311	0.00221	CcSEcCtD
Benzatropine—Tachycardia—Losartan—coronary artery disease	0.00031	0.00221	CcSEcCtD
Benzatropine—Feeling abnormal—Pravastatin—coronary artery disease	0.00031	0.00221	CcSEcCtD
Benzatropine—Body temperature increased—Olmesartan—coronary artery disease	0.000309	0.0022	CcSEcCtD
Benzatropine—Vision blurred—Timolol—coronary artery disease	0.000307	0.00219	CcSEcCtD
Benzatropine—Constipation—Telmisartan—coronary artery disease	0.000307	0.00218	CcSEcCtD
Benzatropine—Hypersensitivity—Simvastatin—coronary artery disease	0.000306	0.00218	CcSEcCtD
Benzatropine—Decreased appetite—Captopril—coronary artery disease	0.000303	0.00216	CcSEcCtD
Benzatropine—Nausea—Acetylsalicylic acid—coronary artery disease	0.000303	0.00216	CcSEcCtD
Benzatropine—Body temperature increased—Niacin—coronary artery disease	0.000302	0.00215	CcSEcCtD
Benzatropine—Feeling abnormal—Trandolapril—coronary artery disease	0.000301	0.00214	CcSEcCtD
Benzatropine—Feeling abnormal—Enalapril—coronary artery disease	0.0003	0.00213	CcSEcCtD
Benzatropine—Constipation—Captopril—coronary artery disease	0.000298	0.00212	CcSEcCtD
Benzatropine—Body temperature increased—Pravastatin—coronary artery disease	0.000297	0.00212	CcSEcCtD
Benzatropine—Tension—Lisinopril—coronary artery disease	0.000297	0.00212	CcSEcCtD
Benzatropine—Feeling abnormal—Telmisartan—coronary artery disease	0.000296	0.00211	CcSEcCtD
Benzatropine—Decreased appetite—Perindopril—coronary artery disease	0.000294	0.0021	CcSEcCtD
Benzatropine—Nervousness—Lisinopril—coronary artery disease	0.000294	0.00209	CcSEcCtD
Benzatropine—Constipation—Perindopril—coronary artery disease	0.00029	0.00206	CcSEcCtD
Benzatropine—Vomiting—Fenofibrate—coronary artery disease	0.000289	0.00206	CcSEcCtD
Benzatropine—Hypersensitivity—Valsartan—coronary artery disease	0.000289	0.00206	CcSEcCtD
Benzatropine—Body temperature increased—Trandolapril—coronary artery disease	0.000289	0.00206	CcSEcCtD
Benzatropine—Body temperature increased—Enalapril—coronary artery disease	0.000287	0.00205	CcSEcCtD
Benzatropine—Feeling abnormal—Captopril—coronary artery disease	0.000287	0.00205	CcSEcCtD
Benzatropine—Rash—Fenofibrate—coronary artery disease	0.000287	0.00204	CcSEcCtD
Benzatropine—Dermatitis—Fenofibrate—coronary artery disease	0.000287	0.00204	CcSEcCtD
Benzatropine—Decreased appetite—Furosemide—coronary artery disease	0.000286	0.00204	CcSEcCtD
Benzatropine—Vision blurred—Lisinopril—coronary artery disease	0.000285	0.00203	CcSEcCtD
Benzatropine—Vomiting—Clopidogrel—coronary artery disease	0.000285	0.00203	CcSEcCtD
Benzatropine—Body temperature increased—Telmisartan—coronary artery disease	0.000284	0.00202	CcSEcCtD
Benzatropine—Vomiting—Lovastatin—coronary artery disease	0.000283	0.00201	CcSEcCtD
Benzatropine—Rash—Clopidogrel—coronary artery disease	0.000282	0.00201	CcSEcCtD
Benzatropine—Dermatitis—Clopidogrel—coronary artery disease	0.000282	0.00201	CcSEcCtD
Benzatropine—Constipation—Furosemide—coronary artery disease	0.000281	0.00201	CcSEcCtD
Benzatropine—Hypersensitivity—Niacin—coronary artery disease	0.000281	0.002	CcSEcCtD
Benzatropine—Rash—Lovastatin—coronary artery disease	0.00028	0.002	CcSEcCtD
Benzatropine—Dermatitis—Lovastatin—coronary artery disease	0.00028	0.00199	CcSEcCtD
Benzatropine—Feeling abnormal—Perindopril—coronary artery disease	0.000279	0.00199	CcSEcCtD
Benzatropine—Dry mouth—Ramipril—coronary artery disease	0.000278	0.00198	CcSEcCtD
Benzatropine—Vomiting—Ezetimibe—coronary artery disease	0.000277	0.00197	CcSEcCtD
Benzatropine—Hypersensitivity—Pravastatin—coronary artery disease	0.000277	0.00197	CcSEcCtD
Benzatropine—Decreased appetite—Losartan—coronary artery disease	0.000276	0.00197	CcSEcCtD
Benzatropine—Body temperature increased—Captopril—coronary artery disease	0.000276	0.00196	CcSEcCtD
Benzatropine—Rash—Ezetimibe—coronary artery disease	0.000275	0.00196	CcSEcCtD
Benzatropine—Dermatitis—Ezetimibe—coronary artery disease	0.000275	0.00196	CcSEcCtD
Benzatropine—Confusional state—Ramipril—coronary artery disease	0.000275	0.00196	CcSEcCtD
Benzatropine—Dry mouth—Timolol—coronary artery disease	0.000272	0.00193	CcSEcCtD
Benzatropine—Constipation—Losartan—coronary artery disease	0.000272	0.00193	CcSEcCtD
Benzatropine—Vomiting—Eplerenone—coronary artery disease	0.000271	0.00193	CcSEcCtD
Benzatropine—Feeling abnormal—Furosemide—coronary artery disease	0.000271	0.00193	CcSEcCtD
Benzatropine—Nausea—Fenofibrate—coronary artery disease	0.00027	0.00193	CcSEcCtD
Benzatropine—Rash—Eplerenone—coronary artery disease	0.000269	0.00192	CcSEcCtD
Benzatropine—Hypersensitivity—Trandolapril—coronary artery disease	0.000269	0.00192	CcSEcCtD
Benzatropine—Dermatitis—Eplerenone—coronary artery disease	0.000269	0.00192	CcSEcCtD
Benzatropine—Confusional state—Timolol—coronary artery disease	0.000268	0.00191	CcSEcCtD
Benzatropine—Hypersensitivity—Enalapril—coronary artery disease	0.000268	0.00191	CcSEcCtD
Benzatropine—Body temperature increased—Perindopril—coronary artery disease	0.000268	0.00191	CcSEcCtD
Benzatropine—Nausea—Clopidogrel—coronary artery disease	0.000266	0.00189	CcSEcCtD
Benzatropine—Tachycardia—Ramipril—coronary artery disease	0.000266	0.00189	CcSEcCtD
Benzatropine—Vomiting—Simvastatin—coronary artery disease	0.000264	0.00188	CcSEcCtD
Benzatropine—Hypersensitivity—Telmisartan—coronary artery disease	0.000264	0.00188	CcSEcCtD
Benzatropine—Nausea—Lovastatin—coronary artery disease	0.000264	0.00188	CcSEcCtD
Benzatropine—Rash—Simvastatin—coronary artery disease	0.000262	0.00187	CcSEcCtD
Benzatropine—Dermatitis—Simvastatin—coronary artery disease	0.000262	0.00187	CcSEcCtD
Benzatropine—Feeling abnormal—Losartan—coronary artery disease	0.000262	0.00186	CcSEcCtD
Benzatropine—Body temperature increased—Furosemide—coronary artery disease	0.00026	0.00185	CcSEcCtD
Benzatropine—Nausea—Ezetimibe—coronary artery disease	0.000259	0.00184	CcSEcCtD
Benzatropine—Nausea—Eplerenone—coronary artery disease	0.000254	0.00181	CcSEcCtD
Benzatropine—Dry mouth—Lisinopril—coronary artery disease	0.000252	0.00179	CcSEcCtD
Benzatropine—Body temperature increased—Losartan—coronary artery disease	0.000251	0.00179	CcSEcCtD
Benzatropine—Vomiting—Valsartan—coronary artery disease	0.00025	0.00178	CcSEcCtD
Benzatropine—Confusional state—Lisinopril—coronary artery disease	0.000249	0.00177	CcSEcCtD
Benzatropine—Vomiting—Olmesartan—coronary artery disease	0.000248	0.00177	CcSEcCtD
Benzatropine—Rash—Valsartan—coronary artery disease	0.000248	0.00176	CcSEcCtD
Benzatropine—Dermatitis—Valsartan—coronary artery disease	0.000247	0.00176	CcSEcCtD
Benzatropine—Nausea—Simvastatin—coronary artery disease	0.000247	0.00176	CcSEcCtD
Benzatropine—Rash—Olmesartan—coronary artery disease	0.000246	0.00176	CcSEcCtD
Benzatropine—Dermatitis—Olmesartan—coronary artery disease	0.000246	0.00175	CcSEcCtD
Benzatropine—Vomiting—Niacin—coronary artery disease	0.000243	0.00173	CcSEcCtD
Benzatropine—Hypersensitivity—Furosemide—coronary artery disease	0.000243	0.00173	CcSEcCtD
Benzatropine—Tachycardia—Lisinopril—coronary artery disease	0.000241	0.00172	CcSEcCtD
Benzatropine—Rash—Niacin—coronary artery disease	0.000241	0.00171	CcSEcCtD
Benzatropine—Dermatitis—Niacin—coronary artery disease	0.000241	0.00171	CcSEcCtD
Benzatropine—Vomiting—Pravastatin—coronary artery disease	0.000239	0.0017	CcSEcCtD
Benzatropine—Rash—Pravastatin—coronary artery disease	0.000237	0.00169	CcSEcCtD
Benzatropine—Dermatitis—Pravastatin—coronary artery disease	0.000237	0.00169	CcSEcCtD
Benzatropine—Decreased appetite—Ramipril—coronary artery disease	0.000237	0.00169	CcSEcCtD
Benzatropine—Hypersensitivity—Losartan—coronary artery disease	0.000234	0.00167	CcSEcCtD
Benzatropine—Nausea—Valsartan—coronary artery disease	0.000233	0.00166	CcSEcCtD
Benzatropine—Constipation—Ramipril—coronary artery disease	0.000233	0.00166	CcSEcCtD
Benzatropine—Nausea—Olmesartan—coronary artery disease	0.000232	0.00165	CcSEcCtD
Benzatropine—Vomiting—Trandolapril—coronary artery disease	0.000232	0.00165	CcSEcCtD
Benzatropine—Decreased appetite—Timolol—coronary artery disease	0.000231	0.00165	CcSEcCtD
Benzatropine—Vomiting—Enalapril—coronary artery disease	0.000231	0.00165	CcSEcCtD
Benzatropine—Rash—Trandolapril—coronary artery disease	0.00023	0.00164	CcSEcCtD
Benzatropine—Dermatitis—Trandolapril—coronary artery disease	0.00023	0.00164	CcSEcCtD
Benzatropine—Rash—Enalapril—coronary artery disease	0.000229	0.00163	CcSEcCtD
Benzatropine—Dermatitis—Enalapril—coronary artery disease	0.000229	0.00163	CcSEcCtD
Benzatropine—Vomiting—Telmisartan—coronary artery disease	0.000228	0.00162	CcSEcCtD
Benzatropine—Nausea—Niacin—coronary artery disease	0.000227	0.00162	CcSEcCtD
Benzatropine—Rash—Telmisartan—coronary artery disease	0.000226	0.00161	CcSEcCtD
Benzatropine—Dermatitis—Telmisartan—coronary artery disease	0.000226	0.00161	CcSEcCtD
Benzatropine—Feeling abnormal—Ramipril—coronary artery disease	0.000224	0.0016	CcSEcCtD
Benzatropine—Nausea—Pravastatin—coronary artery disease	0.000223	0.00159	CcSEcCtD
Benzatropine—Vomiting—Captopril—coronary artery disease	0.000222	0.00158	CcSEcCtD
Benzatropine—Rash—Captopril—coronary artery disease	0.00022	0.00157	CcSEcCtD
Benzatropine—Dermatitis—Captopril—coronary artery disease	0.00022	0.00156	CcSEcCtD
Benzatropine—Feeling abnormal—Timolol—coronary artery disease	0.000219	0.00156	CcSEcCtD
Benzatropine—Nausea—Trandolapril—coronary artery disease	0.000217	0.00154	CcSEcCtD
Benzatropine—Nausea—Enalapril—coronary artery disease	0.000216	0.00154	CcSEcCtD
Benzatropine—Vomiting—Perindopril—coronary artery disease	0.000215	0.00153	CcSEcCtD
Benzatropine—Body temperature increased—Ramipril—coronary artery disease	0.000215	0.00153	CcSEcCtD
Benzatropine—Decreased appetite—Lisinopril—coronary artery disease	0.000215	0.00153	CcSEcCtD
Benzatropine—Rash—Perindopril—coronary artery disease	0.000213	0.00152	CcSEcCtD
Benzatropine—Dermatitis—Perindopril—coronary artery disease	0.000213	0.00152	CcSEcCtD
Benzatropine—Nausea—Telmisartan—coronary artery disease	0.000213	0.00152	CcSEcCtD
Benzatropine—Constipation—Lisinopril—coronary artery disease	0.000211	0.0015	CcSEcCtD
Benzatropine—Body temperature increased—Timolol—coronary artery disease	0.00021	0.0015	CcSEcCtD
Benzatropine—Vomiting—Furosemide—coronary artery disease	0.000209	0.00149	CcSEcCtD
Benzatropine—Rash—Furosemide—coronary artery disease	0.000208	0.00148	CcSEcCtD
Benzatropine—Dermatitis—Furosemide—coronary artery disease	0.000207	0.00148	CcSEcCtD
Benzatropine—Nausea—Captopril—coronary artery disease	0.000207	0.00148	CcSEcCtD
Benzatropine—Feeling abnormal—Lisinopril—coronary artery disease	0.000204	0.00145	CcSEcCtD
Benzatropine—Vomiting—Losartan—coronary artery disease	0.000202	0.00144	CcSEcCtD
Benzatropine—Nausea—Perindopril—coronary artery disease	0.000201	0.00143	CcSEcCtD
Benzatropine—Hypersensitivity—Ramipril—coronary artery disease	0.000201	0.00143	CcSEcCtD
Benzatropine—Rash—Losartan—coronary artery disease	0.0002	0.00143	CcSEcCtD
Benzatropine—Dermatitis—Losartan—coronary artery disease	0.0002	0.00143	CcSEcCtD
Benzatropine—Hypersensitivity—Timolol—coronary artery disease	0.000196	0.0014	CcSEcCtD
Benzatropine—Nausea—Furosemide—coronary artery disease	0.000196	0.00139	CcSEcCtD
Benzatropine—Body temperature increased—Lisinopril—coronary artery disease	0.000195	0.00139	CcSEcCtD
Benzatropine—Nausea—Losartan—coronary artery disease	0.000189	0.00134	CcSEcCtD
Benzatropine—Hypersensitivity—Lisinopril—coronary artery disease	0.000182	0.0013	CcSEcCtD
Benzatropine—Vomiting—Ramipril—coronary artery disease	0.000173	0.00123	CcSEcCtD
Benzatropine—Rash—Ramipril—coronary artery disease	0.000172	0.00122	CcSEcCtD
Benzatropine—Dermatitis—Ramipril—coronary artery disease	0.000172	0.00122	CcSEcCtD
Benzatropine—Vomiting—Timolol—coronary artery disease	0.000169	0.00121	CcSEcCtD
Benzatropine—Rash—Timolol—coronary artery disease	0.000168	0.0012	CcSEcCtD
Benzatropine—Dermatitis—Timolol—coronary artery disease	0.000168	0.00119	CcSEcCtD
Benzatropine—Nausea—Ramipril—coronary artery disease	0.000162	0.00115	CcSEcCtD
Benzatropine—Nausea—Timolol—coronary artery disease	0.000158	0.00113	CcSEcCtD
Benzatropine—Vomiting—Lisinopril—coronary artery disease	0.000157	0.00112	CcSEcCtD
Benzatropine—Rash—Lisinopril—coronary artery disease	0.000156	0.00111	CcSEcCtD
Benzatropine—Dermatitis—Lisinopril—coronary artery disease	0.000156	0.00111	CcSEcCtD
Benzatropine—Modafinil—CYP2C19—coronary artery disease	0.00015	0.0565	CrCbGaD
Benzatropine—Nausea—Lisinopril—coronary artery disease	0.000147	0.00104	CcSEcCtD
Benzatropine—Atomoxetine—CYP2C19—coronary artery disease	0.000129	0.0486	CrCbGaD
Benzatropine—Atomoxetine—HTR2A—coronary artery disease	0.000105	0.0394	CrCbGaD
Benzatropine—Diphenhydramine—CYP2C19—coronary artery disease	0.000104	0.0393	CrCbGaD
Benzatropine—HRH1—Signaling Pathways—S100B—coronary artery disease	8.33e-06	8.66e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—SOCS1—coronary artery disease	8.32e-06	8.65e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—S100B—coronary artery disease	8.3e-06	8.63e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GCLC—coronary artery disease	8.26e-06	8.58e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CETP—coronary artery disease	8.26e-06	8.58e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—SOCS3—coronary artery disease	8.25e-06	8.57e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PRKCE—coronary artery disease	8.24e-06	8.56e-05	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—JAK2—coronary artery disease	8.23e-06	8.55e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—SOCS3—coronary artery disease	8.22e-06	8.54e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—SOCS1—coronary artery disease	8.22e-06	8.54e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—S100B—coronary artery disease	8.2e-06	8.52e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—CTGF—coronary artery disease	8.19e-06	8.51e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—SDC1—coronary artery disease	8.17e-06	8.49e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—TGFBR2—coronary artery disease	8.15e-06	8.47e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—KITLG—coronary artery disease	8.15e-06	8.47e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—TGFBR2—coronary artery disease	8.13e-06	8.44e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—KITLG—coronary artery disease	8.13e-06	8.44e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—HMGCR—coronary artery disease	8.12e-06	8.44e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GOT2—coronary artery disease	8.12e-06	8.44e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—SOCS3—coronary artery disease	8.12e-06	8.43e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—KITLG—coronary artery disease	8.02e-06	8.33e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—TGFBR2—coronary artery disease	8.02e-06	8.33e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MMP3—coronary artery disease	7.97e-06	8.28e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—STAT5A—coronary artery disease	7.97e-06	8.28e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MMP3—coronary artery disease	7.94e-06	8.25e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—STAT5A—coronary artery disease	7.94e-06	8.25e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—STAT5A—coronary artery disease	7.84e-06	8.15e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MMP3—coronary artery disease	7.84e-06	8.15e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PSMA6—coronary artery disease	7.72e-06	8.02e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PSMB5—coronary artery disease	7.72e-06	8.02e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—APOB—coronary artery disease	7.7e-06	8e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—APOB—coronary artery disease	7.68e-06	7.98e-05	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—CXCL8—coronary artery disease	7.63e-06	7.93e-05	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—CXCL8—coronary artery disease	7.61e-06	7.91e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—JAK2—coronary artery disease	7.6e-06	7.89e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—EDN1—coronary artery disease	7.58e-06	7.87e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—APOB—coronary artery disease	7.58e-06	7.87e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—JAK2—coronary artery disease	7.57e-06	7.87e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—EDN1—coronary artery disease	7.55e-06	7.85e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CTGF—coronary artery disease	7.54e-06	7.83e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CCL5—coronary artery disease	7.52e-06	7.81e-05	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—CXCL8—coronary artery disease	7.51e-06	7.81e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CCL5—coronary artery disease	7.5e-06	7.79e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—JAK2—coronary artery disease	7.47e-06	7.77e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—HMGCR—coronary artery disease	7.47e-06	7.76e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GOT2—coronary artery disease	7.47e-06	7.76e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PLCB1—coronary artery disease	7.47e-06	7.76e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—EDN1—coronary artery disease	7.46e-06	7.75e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CSF2—coronary artery disease	7.41e-06	7.7e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—FGF1—coronary artery disease	7.41e-06	7.7e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CCL5—coronary artery disease	7.4e-06	7.69e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CSF2—coronary artery disease	7.38e-06	7.67e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—FGF1—coronary artery disease	7.38e-06	7.67e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—LPL—coronary artery disease	7.35e-06	7.64e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—LPL—coronary artery disease	7.33e-06	7.61e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	7.33e-06	7.61e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CSF2—coronary artery disease	7.29e-06	7.57e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—FGF1—coronary artery disease	7.29e-06	7.57e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—RPS6KB1—coronary artery disease	7.29e-06	7.57e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MEF2C—coronary artery disease	7.29e-06	7.57e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MEF2C—coronary artery disease	7.26e-06	7.55e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—RPS6KB1—coronary artery disease	7.26e-06	7.55e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—ABCA1—coronary artery disease	7.24e-06	7.52e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—LPL—coronary artery disease	7.23e-06	7.52e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—RPS6KB1—coronary artery disease	7.17e-06	7.45e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MEF2C—coronary artery disease	7.17e-06	7.45e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—ITGB3—coronary artery disease	7.1e-06	7.38e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—ITGB3—coronary artery disease	7.08e-06	7.35e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GGT1—coronary artery disease	7.01e-06	7.28e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GOT1—coronary artery disease	7.01e-06	7.28e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—ITGB3—coronary artery disease	6.99e-06	7.26e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—CXCL8—coronary artery disease	6.93e-06	7.2e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—CXCL8—coronary artery disease	6.91e-06	7.18e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PPP2CA—coronary artery disease	6.9e-06	7.17e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PPP2CA—coronary artery disease	6.88e-06	7.14e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PLCB1—coronary artery disease	6.87e-06	7.14e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—CXCL8—coronary artery disease	6.82e-06	7.09e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PPP2CA—coronary artery disease	6.79e-06	7.05e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PRKCD—coronary artery disease	6.77e-06	7.04e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PRKCD—coronary artery disease	6.75e-06	7.02e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PRKCD—coronary artery disease	6.67e-06	6.93e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ABCA1—coronary artery disease	6.66e-06	6.92e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—HTR2A—coronary artery disease	6.63e-06	6.89e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—C3—coronary artery disease	6.62e-06	6.88e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—HTR2A—coronary artery disease	6.61e-06	6.87e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—C3—coronary artery disease	6.6e-06	6.86e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—HTR2A—coronary artery disease	6.52e-06	6.78e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—C3—coronary artery disease	6.51e-06	6.77e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GGT1—coronary artery disease	6.45e-06	6.7e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GOT1—coronary artery disease	6.45e-06	6.7e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—HIF1A—coronary artery disease	6.31e-06	6.56e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GSTP1—coronary artery disease	6.3e-06	6.54e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—HIF1A—coronary artery disease	6.29e-06	6.54e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—AGT—coronary artery disease	6.29e-06	6.54e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—AGT—coronary artery disease	6.27e-06	6.51e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	6.24e-06	6.48e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—HIF1A—coronary artery disease	6.21e-06	6.45e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—HMOX1—coronary artery disease	6.21e-06	6.45e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—AGT—coronary artery disease	6.19e-06	6.43e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—LEP—coronary artery disease	6.16e-06	6.4e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—APOE—coronary artery disease	6.16e-06	6.4e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—APOE—coronary artery disease	6.14e-06	6.38e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—LEP—coronary artery disease	6.14e-06	6.38e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—CAT—coronary artery disease	6.13e-06	6.37e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—APOA1—coronary artery disease	6.09e-06	6.33e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—APOA1—coronary artery disease	6.07e-06	6.31e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—LEP—coronary artery disease	6.06e-06	6.3e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—APOE—coronary artery disease	6.06e-06	6.3e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—KDR—coronary artery disease	6.04e-06	6.27e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—KDR—coronary artery disease	6.02e-06	6.25e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MAPK14—coronary artery disease	6e-06	6.23e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—APOA1—coronary artery disease	5.99e-06	6.23e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MAPK14—coronary artery disease	5.98e-06	6.21e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—APOB—coronary artery disease	5.95e-06	6.18e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—KDR—coronary artery disease	5.94e-06	6.17e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MAPK14—coronary artery disease	5.9e-06	6.13e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—ESR1—coronary artery disease	5.88e-06	6.11e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—ESR1—coronary artery disease	5.87e-06	6.09e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—FN1—coronary artery disease	5.81e-06	6.04e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—F2—coronary artery disease	5.81e-06	6.04e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—FN1—coronary artery disease	5.79e-06	6.02e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—F2—coronary artery disease	5.79e-06	6.02e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GSTP1—coronary artery disease	5.79e-06	6.02e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—ESR1—coronary artery disease	5.79e-06	6.02e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—IL6ST—coronary artery disease	5.79e-06	6.01e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GSTM1—coronary artery disease	5.79e-06	6.01e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	5.77e-06	6e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—NFKBIA—coronary artery disease	5.74e-06	5.97e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	5.74e-06	5.96e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	5.72e-06	5.95e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—F2—coronary artery disease	5.72e-06	5.94e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—FN1—coronary artery disease	5.72e-06	5.94e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—HMOX1—coronary artery disease	5.71e-06	5.93e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	5.7e-06	5.92e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—LPL—coronary artery disease	5.68e-06	5.9e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	5.65e-06	5.87e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CAT—coronary artery disease	5.64e-06	5.86e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—KIT—coronary artery disease	5.56e-06	5.78e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—KIT—coronary artery disease	5.54e-06	5.76e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GPX1—coronary artery disease	5.54e-06	5.76e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—KIT—coronary artery disease	5.47e-06	5.69e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—APOB—coronary artery disease	5.47e-06	5.68e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—CD36—coronary artery disease	5.4e-06	5.61e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—GSK3B—coronary artery disease	5.34e-06	5.55e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PPP2CA—coronary artery disease	5.33e-06	5.54e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GSTM1—coronary artery disease	5.32e-06	5.53e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	5.32e-06	5.53e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—POMC—coronary artery disease	5.29e-06	5.5e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CREB1—coronary artery disease	5.29e-06	5.5e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—POMC—coronary artery disease	5.28e-06	5.48e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CREB1—coronary artery disease	5.28e-06	5.48e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	5.25e-06	5.46e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—LPL—coronary artery disease	5.22e-06	5.43e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—POMC—coronary artery disease	5.21e-06	5.41e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CREB1—coronary artery disease	5.21e-06	5.41e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CCL2—coronary artery disease	5.18e-06	5.38e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—IL6R—coronary artery disease	5.16e-06	5.37e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CCL2—coronary artery disease	5.16e-06	5.37e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—IL6R—coronary artery disease	5.15e-06	5.35e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—MTHFR—coronary artery disease	5.11e-06	5.31e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CCL2—coronary artery disease	5.1e-06	5.3e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GPX1—coronary artery disease	5.1e-06	5.3e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—IGF1—coronary artery disease	5.09e-06	5.29e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—IL6R—coronary artery disease	5.08e-06	5.28e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—IGF1—coronary artery disease	5.08e-06	5.27e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—MAPK1—coronary artery disease	5.07e-06	5.27e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	5.05e-06	5.25e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—IGF1—coronary artery disease	5.01e-06	5.21e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	4.99e-06	5.18e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CD36—coronary artery disease	4.96e-06	5.16e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	4.9e-06	5.09e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—AGT—coronary artery disease	4.86e-06	5.05e-05	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—PIK3CA—coronary artery disease	4.84e-06	5.03e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—SERPINE1—coronary artery disease	4.84e-06	5.02e-05	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	4.83e-06	5.02e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	4.82e-06	5.01e-05	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	4.77e-06	4.95e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—APOE—coronary artery disease	4.76e-06	4.95e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	4.76e-06	4.94e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—APOA1—coronary artery disease	4.71e-06	4.89e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—MTHFR—coronary artery disease	4.7e-06	4.89e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—FGF2—coronary artery disease	4.68e-06	4.86e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—FGF2—coronary artery disease	4.67e-06	4.85e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—NOS3—coronary artery disease	4.62e-06	4.8e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—FGF2—coronary artery disease	4.61e-06	4.79e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—NOS3—coronary artery disease	4.6e-06	4.78e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—NOS3—coronary artery disease	4.54e-06	4.72e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.51e-06	4.68e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—JAK2—coronary artery disease	4.49e-06	4.66e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—JAK2—coronary artery disease	4.47e-06	4.65e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—AGT—coronary artery disease	4.47e-06	4.64e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—JAK2—coronary artery disease	4.42e-06	4.59e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	4.4e-06	4.57e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	4.38e-06	4.56e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—APOE—coronary artery disease	4.38e-06	4.55e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—APOA1—coronary artery disease	4.33e-06	4.5e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	4.33e-06	4.5e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PPARG—coronary artery disease	4.15e-06	4.31e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CXCL8—coronary artery disease	4.1e-06	4.26e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—POMC—coronary artery disease	4.09e-06	4.25e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	4.08e-06	4.24e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	4.03e-06	4.19e-05	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	3.96e-06	4.11e-05	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	3.94e-06	4.1e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CASP3—coronary artery disease	3.92e-06	4.07e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CASP3—coronary artery disease	3.91e-06	4.06e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—IL6—coronary artery disease	3.89e-06	4.05e-05	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	3.89e-06	4.04e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—IL6—coronary artery disease	3.88e-06	4.03e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CASP3—coronary artery disease	3.86e-06	4.01e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—IL6—coronary artery disease	3.83e-06	3.98e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CCND1—coronary artery disease	3.82e-06	3.96e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PPARG—coronary artery disease	3.81e-06	3.96e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CCND1—coronary artery disease	3.8e-06	3.95e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—POMC—coronary artery disease	3.76e-06	3.91e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CCND1—coronary artery disease	3.75e-06	3.9e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—ALB—coronary artery disease	3.73e-06	3.87e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MMP9—coronary artery disease	3.7e-06	3.85e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MMP9—coronary artery disease	3.69e-06	3.84e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MMP9—coronary artery disease	3.65e-06	3.79e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—AKT1—coronary artery disease	3.59e-06	3.73e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	3.58e-06	3.72e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—NOS3—coronary artery disease	3.57e-06	3.71e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	3.54e-06	3.67e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ALB—coronary artery disease	3.43e-06	3.56e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—VEGFA—coronary artery disease	3.33e-06	3.46e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	3.32e-06	3.45e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—NOS3—coronary artery disease	3.28e-06	3.41e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	3.27e-06	3.4e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PTGS2—coronary artery disease	3.26e-06	3.39e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—TGFB1—coronary artery disease	3.05e-06	3.17e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	3.04e-06	3.16e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	3e-06	3.12e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PTGS2—coronary artery disease	3e-06	3.12e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MAPK1—coronary artery disease	2.99e-06	3.11e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	2.98e-06	3.1e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	2.95e-06	3.06e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	2.6e-06	2.7e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	2.59e-06	2.69e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	2.56e-06	2.66e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—IL6—coronary artery disease	2.3e-06	2.39e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—IL6—coronary artery disease	2.29e-06	2.38e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—IL6—coronary artery disease	2.26e-06	2.35e-05	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—AKT1—coronary artery disease	2.12e-06	2.21e-05	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—AKT1—coronary artery disease	2.12e-06	2.2e-05	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—AKT1—coronary artery disease	2.09e-06	2.17e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PIK3CA—coronary artery disease	2.01e-06	2.09e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.85e-06	1.92e-05	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—AKT1—coronary artery disease	1.64e-06	1.7e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—AKT1—coronary artery disease	1.51e-06	1.57e-05	CbGpPWpGaD
